Kevin Kunzmann

Covering medicine, tweeting about it too. Got my degree from @RowanUniversity, and my anxiety from the @Mets.

[NeurologyLive® @neurology_live]

Reporting live from #AAN✅ in Chicago 🌆! Here for the biggest meeting in #neurology, stay tuned for our coverage all week @AANmember

https://t.co/DeblrFaiVt

[Kevin Kunzmann @NotADoctorKevin]

New episode of #TheHealthBeat! Introducing the PREVENT equation, a 10 and 30-year #cardiovascular risk calculator that leverages data from standard primary care physicals.

Watch our episode on the new tool and its supporting guidelines on YouTube: https://t.co/V0pBkbzGsr

[Kevin Kunzmann @NotADoctorKevin]

New episode of #TheHealthBeat! An interview with Joshua Fitch of @ContempOBGYN to learn about the first endometriosis diagnosis guidelines, published by @acog last month.

Watch the episode (and our full weekly series) on YouTube: https://t.co/vFFBap1kuv

[Kevin Kunzmann @NotADoctorKevin]

New episode of #TheHealthBeat!

I dive into the recently proposed changes to the DSM with Leah Kuntz of @PsychTimes, featuring expert perspective and excerpts from their latest cover story.

Watch the episode and subscribe to the show here: https://t.co/o1gNBf4as7

[Kevin Kunzmann @NotADoctorKevin]

Let me tell you about pediatric #OIT for peanut allergies while I take my son — an OIT graduate — to spring training.

Learn more about #allergy treatment at @TheEduPatient

[Kevin Kunzmann @NotADoctorKevin]

New episode of #TheHealthBeat is live!

I dive into the new dietary guidance and the @USDA & @HHSGov "Eat Real Food" campaign with Abby Brooks, MA, of @HCPLiveNews.

Watch and subscribe to the series here: https://t.co/vp9ph2PGaC

[Kevin Kunzmann @NotADoctorKevin]

You know its name and you likely know someone on it right now. Semaglutide (#Ozempic) is the biggest drug in the world, and it's now the target of compound manufacturers and the greater consumer industry.

Watch Ep. 2 of #TheHealthBeat to learn more: https://t.co/qSMYINcSAS

[Kevin Kunzmann @NotADoctorKevin]

Today, the @CDCgov reported that we surpassed 900 known cases of #measles in the first 44 days of 2026.

That number is high & climbing fast — but experts believe it's likely even greater.

Watch ep. 1 of The Health Beat, with @Contagion_Live experts: https://t.co/VXxshwUTRd

[Psychiatric Times @PsychTimes]

💊The interactive February digital issue of Psychiatric Times is now live! This month, our exclusively-online issue puts a spotlight on antidepressant withdrawal.

Explore the issue now and follow along as articles are shared throughout the month. https://t.co/CCUasDbSza

[Kevin Kunzmann @NotADoctorKevin]

Let me tell you about morning stiffness while I make some salsa verde for the Super Bowl.

@TheEduPatient

[Kevin Kunzmann @NotADoctorKevin]

Let me tell you about this current flu season while I shovel us out of a snowstorm.

Follow @TheEduPatient for more #flu and other viral season updates

[Health Affairs @Health_Affairs]

In their new Forefront article, Kathleen Noonan + @MaryDNaylor from @camdenhealth + @Penn discuss how, as our nation ages, it is time to design new place-based care models that capitalize on the strengths of our old-style institutional care and current approaches to community-based services. https://t.co/ZX5HdCD1Z8

[Kevin Kunzmann @NotADoctorKevin]

Train-bound for my first ever ASTRO meeting! Excited to get into all the new updates in prostate cancer and more for @UrologyTimes. Hope you follow along!

#ASTRO24

[Urology Times @UrologyTimes]

We're making our maiden voyage to #ASTRO24 in Washington DC this weekend! Follow along for our live coverage of the annual #oncology meeting, including new data and on-site interviews!

Stay tuned for more: https://t.co/O6ESKoEDTo

[HCPLive @HCPLiveNews]

BREAKING: The US FDA has announced the approval xanomeline and trospium chloride capsules (Cobenfy), for #schizophrenia.

https://t.co/nfpTXXxyxU

[Kevin Kunzmann @NotADoctorKevin]

Today's #AdComm meeting is coming close to an end—our colleague Hannah Clarke has created a truly robust live journal of the daylong deliberations.

Catch up on the discussion around the #sulopenem FDA application for UTIs at the link before the big vote! #IDTwitter #UroTwitter

[Urology Times @UrologyTimes]

🧵The FDA Antimicrobial Drugs Advisory Committee is set to meet today to discuss the submitted NDA for oral sulopenem for uncomplicated urinary tract infection.

Follow along with Urology Times' live report of the meeting below. #urology #urologist https://t.co/H7QqQNyVXy

[Matt Hoffman @byMattHoffman]

I'm heading to Copenhagen for #ECTRIMS2024 in a couple of weeks for @neurology_live. It's always one of my favorite meetings, and the program is (once again) stacked this year.

Let me know if you're presenting there and would like to chat about your work (or just say hi)!

[HCPLive @HCPLiveNews]

New #Lungcast!

For Back to School, the @LungAssociation spoke with @DrJuanitaMora and @PedLungDoc on a number of pediatric respiratory health topics—#RSV risk, vaping, and the dreaded #Asthma Peak Week.

Watch / listen to the full episode here: https://t.co/3Uhwb6L36X

[Kevin Kunzmann @NotADoctorKevin]

WARDELL

[Tim Smith @MedMediaTim]

Had another opportunity to interview @RajMDPhD on his team's findings on the prevalence of #SeborrheicDermatitis.

Dr. Chovatiya's interviews with @HCPLiveNews are always a highlight of our #dermatology coverage. Informative as always!

Check it out here: https://t.co/iwKfkwPyMz

[Kevin Kunzmann @NotADoctorKevin]

I’m not even sick of the movie, it’s just these lyrics gutting me before 8 AM every day

[Kevin Kunzmann @NotADoctorKevin]

Sabotaging my toddler’s obsession with Lion King because listening to Circle of Life every day is giving me existential dread